Reviews desk
Kevin Turner reviews the companies selling GLP-1 treatment to Americans. One company at a time, priced month to month, with the part they'd rather you scrolled past.
He's worked in and around the pharmaceutical industry for over a decade, which mostly means he knows what a price is doing when it's advertised as "as low as." It's almost always a prepay. The number on the card today is bigger. That single habit — reading the ladder instead of the headline — is most of what these reviews are.
He's not a licensed clinician, and this isn't medical advice. Prices are read off the company's own site and dated; when a company won't publish one before an intake, the review says that rather than estimating. GLP America earns a commission when readers start care through some of these links. Partner links are marked wherever they appear.
The rules behind every review are on the method page. Errors go to desk@glpamerica.org and get fixed with a date on them.